视频

介绍视频

产品介绍

Planova™ S20N介绍
Planova™ BioEX介绍

过滤操作步骤

S20N小试操作指南
S20N小试操作指南
BioEX小试操作指南
BioEX小试操作指南
Virus Safety for Biotherapeutics: Testing and Clearance Strategies Following the ICH Q5A Revision
Virus Safety for Biotherapeutics: Testing and Clearance Strategies Following the ICH Q5A Revision
Planova S20N evaluation on PCC and IgG products
Planova S20N evaluation on PCC and IgG products
Addressing Continuous Bioprocessing Challenges From Virus Removal Perspective
Addressing Continuous Bioprocessing Challenges From Virus Removal Perspective
New Generation Planova™ S20N Demonstrates Robust Performance for Multi-Specific Antibodies
New Generation Planova™ S20N Demonstrates Robust Performance for Multi-Specific Antibodies
Nanofiltration Strategies in Plasma Protein Process Development
Nanofiltration Strategies in Plasma Protein Process Development
BioEX的特点及应用
BioEX的特点及应用
成功的病毒验证的重要考虑因素
成功的病毒验证的重要考虑因素
使用Planova BioEX可减少开发病毒过滤工艺中的所需资源
使用Planova™ BioEX可减少开发病毒过滤工艺中的所需资源
病毒过滤工艺中使用Planova BioEX的生产注意事项
病毒过滤工艺中使用Planova™ BioEX的生产注意事项